Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
1.970
+0.060 (3.14%)
Oct 28, 2026, 2:38 PM EDT - Market open
Jyong Biotech Market Cap
Jyong Biotech has a market cap or net worth of $146.24 million as of October 28, 2026. It is the 22,829th most valuable company in the world and the 3,840th biggest in the United States. Its market cap has decreased by 96.87% in one year.
Market Cap
146.24M
Enterprise Value
163.61M
1-Year Change
-96.87%
Global Rank
Country Rank
#3,840 United States
Category
ChartMarket Cap Chart
Since June 17, 2025, Jyong Biotech's market cap has decreased from $777.46M to $146.24M, a decrease of -81.19%. That is a compound annual growth rate of -70.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 131.39M | -56.74% |
| Dec 31, 2025 | 303.76M | -60.93% |
| Jun 17, 2025 | 777.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 138.58M |
| Atrium Therapeutics | 137.70M |
| AN2 Therapeutics | 136.98M |
| Innate Pharma | 136.43M |
| Compass Therapeutics | 134.56M |
| Cue Biopharma | 134.03M |
| Nkarta | 131.07M |
| TuHURA Biosciences | 130.00M |